Neurogenic plasticity of mesenchymal stem cell, an alluring cellular replacement for traumatic brain injury - PubMed (original) (raw)
Review
Neurogenic plasticity of mesenchymal stem cell, an alluring cellular replacement for traumatic brain injury
Soumya Pati et al. Curr Stem Cell Res Ther. 2016.
Abstract
Traumatic brain injury (TBI) imposes horrendous neurophysiological alterations leading to most devastating forms of neuro-disability. Which includes impaired cognition, distorted locomotors activity and psychosomatic disability in both youths and adults. Emerging evidence from recent studies has identified mesenchymal stem cells (MSCs) as one of the promising category of stem cells having excellent neuroregenerative capability in TBI victims. Some of the clinical and animal studies reported that MSCs transplantation could cure neuronal damage as well as improve cognitive and locomotors behaviors in TBI. However, mechanism behind their broad spectrum neuroregenerative potential in TBI has not been reviewed yet. Therefore, in the present article, we present a comprehensive data on the important attributes of MSCs, such as neurotransdifferentiation, neuroprotection, axonal repair and plasticity, maintenance of blood-brain integrity, reduction of reactive oxygen species (ROS) and immunomodulation. We have reviewed in detail the crucial neurogenic capabilities of MSCs in vivo and provided consolidated knowledge regarding their cellular remodeling in TBI for future therapeutic implications.
Similar articles
- Transplantation of RADA16-BDNF peptide scaffold with human umbilical cord mesenchymal stem cells forced with CXCR4 and activated astrocytes for repair of traumatic brain injury.
Shi W, Huang CJ, Xu XD, Jin GH, Huang RQ, Huang JF, Chen YN, Ju SQ, Wang Y, Shi YW, Qin JB, Zhang YQ, Liu QQ, Wang XB, Zhang XH, Chen J. Shi W, et al. Acta Biomater. 2016 Nov;45:247-261. doi: 10.1016/j.actbio.2016.09.001. Epub 2016 Sep 2. Acta Biomater. 2016. PMID: 27592818 - Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury.
Menge T, Zhao Y, Zhao J, Wataha K, Gerber M, Zhang J, Letourneau P, Redell J, Shen L, Wang J, Peng Z, Xue H, Kozar R, Cox CS Jr, Khakoo AY, Holcomb JB, Dash PK, Pati S. Menge T, et al. Sci Transl Med. 2012 Nov 21;4(161):161ra150. doi: 10.1126/scitranslmed.3004660. Sci Transl Med. 2012. PMID: 23175708 Free PMC article. - Effects of over-expression of SOD2 in bone marrow-derived mesenchymal stem cells on traumatic brain injury.
Shi X, Bai Y, Zhang G, Liu Y, Xiao H, Liu X, Zhang W. Shi X, et al. Cell Tissue Res. 2018 Apr;372(1):67-75. doi: 10.1007/s00441-017-2716-7. Epub 2017 Oct 30. Cell Tissue Res. 2018. PMID: 29082445 - Can Mesenchymal Stem Cells Act Multipotential in Traumatic Brain Injury?
Dehghanian F, Soltani Z, Khaksari M. Dehghanian F, et al. J Mol Neurosci. 2020 May;70(5):677-688. doi: 10.1007/s12031-019-01475-w. Epub 2020 Jan 2. J Mol Neurosci. 2020. PMID: 31897971 Review. - Genetically Modified Mesenchymal Stem Cells: The Next Generation of Stem Cell-Based Therapy for TBI.
Shahror RA, Wu CC, Chiang YH, Chen KY. Shahror RA, et al. Int J Mol Sci. 2020 Jun 5;21(11):4051. doi: 10.3390/ijms21114051. Int J Mol Sci. 2020. PMID: 32516998 Free PMC article. Review.
Cited by
- Isolation and Characterization of Neural Progenitor Cells From Bone Marrow in Cell Replacement Therapy of Brain Injury.
Bai WF, Zhang Y, Xu W, Li W, Li M, Yuan F, Luo X, Zhang M. Bai WF, et al. Front Cell Neurosci. 2020 Mar 12;14:49. doi: 10.3389/fncel.2020.00049. eCollection 2020. Front Cell Neurosci. 2020. PMID: 32226361 Free PMC article. - Conditioned Medium of Bone Marrow-Derived Mesenchymal Stromal Cells as a Therapeutic Approach to Neuropathic Pain: A Preclinical Evaluation.
Gama KB, Santos DS, Evangelista AF, Silva DN, de Alcântara AC, Dos Santos RR, Soares MBP, Villarreal CF. Gama KB, et al. Stem Cells Int. 2018 Jan 30;2018:8179013. doi: 10.1155/2018/8179013. eCollection 2018. Stem Cells Int. 2018. PMID: 29535781 Free PMC article. - Diffuse white matter response in trauma-injured brain to bone marrow stromal cell treatment detected by diffusional kurtosis imaging.
Li L, Chopp M, Ding G, Davoodi-Bojd E, Li Q, Mahmood A, Xiong Y, Jiang Q. Li L, et al. Brain Res. 2019 Aug 15;1717:127-135. doi: 10.1016/j.brainres.2019.04.020. Epub 2019 Apr 19. Brain Res. 2019. PMID: 31009610 Free PMC article. - Usage of Human Mesenchymal Stem Cells in Cell-based Therapy: Advantages and Disadvantages.
Kim HJ, Park JS. Kim HJ, et al. Dev Reprod. 2017 Mar;21(1):1-10. doi: 10.12717/DR.2017.21.1.001. Epub 2017 Mar 31. Dev Reprod. 2017. PMID: 28484739 Free PMC article. Review. - Bone marrow stromal cells promote neuromotor functional recovery, via upregulation of neurotrophic factors and synapse proteins following traumatic brain injury in rats.
Feng Y, Ju Y, Cui J, Wang L. Feng Y, et al. Mol Med Rep. 2017 Jul;16(1):654-660. doi: 10.3892/mmr.2017.6619. Epub 2017 May 25. Mol Med Rep. 2017. PMID: 28560414 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources